Internal Medicine · Wilmington, DE
NPI
1558463299
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2101 Foulk Rd
Wilmington, DE, 19810
Phone (302) 475-2535
Groups this clinician bills Medicare through
Medicare paid, 2024
$343K
8,171 services
Medicare patients, 2024
819
Average age 76
Drug cost, 2024
$1.4M
12,774 prescriptions
Company payments, 2025
$1,224
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Armand N Desanctis Jr. was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 2,284 times for 736 patients. In total Armand N Desanctis Jr. billed 8,171 services in 29 codes, and Medicare paid $343K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-02-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 2,284 | 736 | $11.97 | $27K |
| 99213 Office E&M - Established | Office | 1,815 | 674 | $61.23 | $111K |
| 99212 Office E&M - Established | Office | 907 | 460 | $36.98 | $34K |
| 99214 Office E&M - Established | Office | 585 | 370 | $95.40 | $56K |
| 90662 Vaccine Product | Office | 417 | 415 | $78.98 | $33K |
| G0008 Administration of influenza virus vaccine | Office | 416 | 414 | $31.89 | $13K |
| 96372 Injection Administration | Office | 291 | 102 | $9.82 | $2,859 |
| 99497 Care Management/Coordination | Office | 275 | 274 | $23.86 | $6,561 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 260 | 260 | $18.46 | $4,799 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 257 | 257 | $126.92 | $33K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 196 | 26 | $0.88 | $172 |
| 98967 Telephone Services | Office | 85 | 75 | $15.01 | $1,276 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 69 | 58 | $0.08 | $5.56 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 55 | 50 | $158.19 | $8,700 |
| 93000 Electrocardiogram | Office | 48 | 47 | $10.68 | $513 |
By year: 2022 $293K for 5,148 services; 2023 $303K for 5,438 services; 2024 $343K for 8,171 services.
Medicare prescription drug claims, 2024
In 2024, the drug Armand N Desanctis Jr. prescribed most often to Medicare patients was Atorvastatin Calcium, with 785 prescriptions and refills. In total Armand N Desanctis Jr. wrote 12,774 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 785 | 2,280 | 236 | $12K |
| Rosuvastatin Calcium Generic | 772 | 2,286 | 242 | $15K |
| Levothyroxine Sodium Generic | 627 | 1,812 | 183 | $6,705 |
| Olmesartan Medoxomil Generic | 559 | 1,601 | 160 | $15K |
| Amlodipine Besylate Generic | 467 | 1,344 | 144 | $3,762 |
| Alprazolam Generic | 466 | 623 | 104 | $4,524 |
| Omeprazole Generic | 390 | 1,120 | 121 | $7,270 |
| Doxycycline Hyclate Generic | 315 | 321 | 249 | $2,963 |
| Mounjaro Tirzepatide | 311 | 408 | 56 | $419K |
| Methylprednisolone Generic | 299 | 299 | 229 | $1,889 |
| Metoprolol Succinate Generic | 293 | 845 | 96 | $5,328 |
| Losartan Potassium Generic | 277 | 820 | 84 | $3,199 |
| Pravastatin Sodium Generic | 245 | 730 | 70 | $2,913 |
| Valsartan Generic | 208 | 609 | 61 | $6,457 |
| Tramadol Hcl Generic | 203 | 215 | 49 | $1,670 |
Brand drugs: 1,536 claims; generic drugs: 11,211 claims; opioid claims: 354.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Armand N Desanctis Jr. $1,224 ($1,224 in general payments such as food, travel and fees) from 14 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $361.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 9 | $361 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $180 |
| Astellas Pharma US Inc 4503.T | 13 | $168 |
| Lilly USA, LLC LLY | 6 | $117 |
| Novo Nordisk Inc NVO | 5 | $92.63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $79.74 |
| Sanofi Pasteur Inc. SNY | 2 | $56.71 |
| GlaxoSmithKline, LLC. GSK | 3 | $48.32 |
| Tactile Systems Technology Inc TCMD | 1 | $26.79 |
| Abbott Laboratories ABT | 1 | $26.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.